Target intelligence / Profile preview

Lipid bilayer phospholipids and membrane-associated free radicals

Molecular classification
Lipid, Reactive oxygen species, Other
01

Overview

The lipid bilayer phospholipids form the essential structural framework of cellular and organelle membranes, maintaining cellular compartmentalization and fluidity (Ayala et al., 2014, PMID: 24926803). Membrane-associated free radicals, including reactive oxygen species (ROS) and lipid peroxyl radicals, are highly reactive intermediates that can trigger lipid peroxidation, a process that degrades these phospholipids and compromises membrane integrity (Gaschler & Stockwell, 2017, PMID: 28213273). This oxidative damage is a hallmark of various pathological states, particularly neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS) and ischemia-reperfusion injury in stroke (Watanabe et al., 1994, PMID: 8034141). Therapeutic strategies targeting this system involve lipophilic antioxidants and radical scavengers, such as Edaravone and Vitamin E, which localize within the membrane to neutralize radicals and terminate the peroxidation chain reaction (NIH, 2023). By protecting the lipid environment, these interventions aim to preserve the function of membrane-bound proteins and prevent oxidative-stress-induced cell death (Repetto et al., 2012, PMID: 23110314).

Other names
Cell membrane phospholipidsMembrane lipidsLipid peroxyl radicalsMembrane-bound reactive oxygen speciesPhospholipid bilayer
02

Mechanism of action

Drugs targeting this complex act primarily as chain-breaking antioxidants or free radical scavengers. They partition into the hydrophobic core of the lipid bilayer where they donate hydrogen atoms to lipid peroxyl radicals, thereby neutralizing them and preventing the propagation of lipid peroxidation (Ayala et al., 2014, PMID: 24926803).

03

Biological functions

Membrane structural integrityCellular compartmentalizationOxidative stress responseSignal transductionMembrane fluidity
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseIschemia-reperfusion injuryCancerAgingAtherosclerosis
05

Safety considerations

Interference with essential redox signalingPotential pro-oxidant effects at high concentrationsPoor aqueous solubility and bioavailabilityNon-specific distribution
06

Interacting drugs

Edaravone

4 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)4-Hydroxynonenal (4-HNE)F2-isoprostanesProtein carbonyls

Beyond the preview

Go deeper on Lipid bilayer phospholipids and membrane-associated free radicals.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid bilayer phospholipids and membrane-associated free radicals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call